“I’ll wait for confirmation.” “I want to see one more quarter.” “Let me check after the budget.” Indian retail investors say these phrases hundreds of times a year — and most of the time, the underlying psychological driver is not analysis. It is regret aversion: the dread of taking a decision that, in hindsight, will look like a mistake. Regret aversion is the silent reason why so many disciplined Indian savers stay parked in fixed deposits while equity SIPs deliver 14–16% CAGR around them, why investors sell quality compounders the moment they turn green, and why portfolios accumulate seven-year-old losers no one has the stomach to cut. This article unpacks the academic foundation of regret theory, the Indian retail evidence, the counter-measures professional investors use, and an illustrative case from Titan Biotech Ltd (BSE: 524717) showing how an anti-regret process discipline looks at the corporate level.
The Bias: What Regret Aversion Really Is
Regret aversion (also called regret aversion bias or regret theory) is the tendency to anticipate the painful feeling of having made a wrong decision and to bias one’s choices to minimize that anticipated regret — even when it leads to objectively worse expected outcomes. It is closely related to, but distinct from, loss aversion. Loss aversion concerns the asymmetric pain of losing money. Regret aversion concerns the asymmetric pain of having chosen the action that produced the loss.
The formal academic foundation of regret theory was established in two landmark 1982 papers published in the same year: David Bell’s “Regret in Decision Making Under Uncertainty” (Operations Research, Vol. 30, No. 5, 1982) and Graham Loomes and Robert Sugden’s “Regret Theory: An Alternative Theory of Rational Choice Under Uncertainty” (The Economic Journal, Vol. 92, No. 368, 1982). Both papers showed that incorporating an anticipated-regret term into the utility function explains decision patterns that classical expected utility theory cannot — including the Allais paradox, status-quo bias and the disposition effect.
The intuition is simple. Suppose you are choosing between two options, A and B. Classical theory says you compute the expected utility of each and pick the higher one. Regret theory says you also implicitly compute “if I pick A and B turns out to have been the better choice, how much will it sting?” — and you weigh that anticipated sting into the decision. Because regret feels worse than an equivalent loss from an unchosen path (the so-called commission–omission asymmetry), the result is often inaction: refusing to choose at all.
The Underlying Psychology: Why Inaction Feels Safer Than Action
Daniel Kahneman and Amos Tversky’s earlier work on prospect theory (“Prospect Theory: An Analysis of Decision under Risk”, Econometrica, 1979) had already established that losses loom larger than gains by a factor of roughly 2.0–2.5×. Regret theory layers a second asymmetry on top: losses from action feel worse than losses from inaction. Kahneman and Tversky themselves studied this in 1982 (“The Psychology of Preferences”, Scientific American) using the now-classic stockbroker example — a man who switches from Stock A to Stock B and watches Stock A then go up feels much greater regret than a man who simply held Stock B and watched Stock A go up by the same amount.
Three psychological mechanisms reinforce regret aversion:
(1) Counterfactual thinking. The human mind reflexively constructs “what-if” simulations. The closer the counterfactual feels to reality (a near-miss), the sharper the regret. Indian investors who sold a quality compounder six months before a 60% rally remember it for years.
(2) Self-blame attribution. Regret carries a moral signal — “I should have known better.” Losses from inaction are blamed on circumstance (“the market was bad”); losses from action are blamed on the self.
(3) The status-quo default. Inaction never requires justification. Action does. So when uncertainty is high, the path of least psychological resistance is to do nothing — which compounds badly when the optimal financial decision was to act (start the SIP, rebalance, exit the loss).
The Indian Manifestation: Where Regret Aversion Shows Up in Retail Portfolios
Indian retail data — drawn from SEBI bulletins, NSE annual reports, and AMFI quarterly disclosures — shows regret-aversion fingerprints across several distinct patterns:
(a) The “Frozen FD” problem. Per RBI’s Handbook of Statistics on the Indian Economy 2024–25, Indian household financial savings remain disproportionately tilted toward bank deposits — over ₹190 lakh crore in scheduled commercial bank deposits as of FY25, against a free-float equity market cap of ~₹240 lakh crore. The behavioral driver is not absence of equity literacy; it is anticipated regret. A saver who shifts from FD to equity and watches a 25% drawdown experiences both the loss and the regret of having moved. The saver who stays in the FD experiences neither — even though the real (inflation-adjusted) FD return has averaged near zero over the last decade.
(b) The “post-rally entry” reflex. AMFI monthly equity inflow data shows a recurring pattern: SIP folios surge after 12-month market rallies (e.g., the ₹2.46 lakh crore equity-MF net inflow during FY24, which followed the Nifty’s 28% FY24 rally) and slow during corrections. This is regret aversion working in reverse — the regret of “having missed it” finally exceeds the regret of “buying near the top”. Investors enter at exactly the wrong moment. SEBI’s annual investor survey (2022) reported that 41% of new equity entrants between 2020–22 had begun investing within six months of the March 2020 lows being decisively breached on the upside.
(c) The “sell-into-strength too early” pattern. Prof. V. Ravi Anshuman (IIM Bangalore) and co-authors have documented in Indian-market behavioral-finance work that retail investors realize gains 2.4× faster than they realize losses on the same security — a sharper version of the Shefrin-Statman “disposition effect”. The driver is regret aversion of two flavours: realizing a profit closes the loop on the regret-of-future-reversal, while not realizing a loss avoids the regret-of-having-bought-at-all.
(d) The “won’t sell my Yes Bank” phenomenon. SEBI’s quarterly demat-account data shows that as of FY25, more than 4.2 crore unique demat accounts continue to hold defunct or near-defunct stocks (DHFL, Reliance Capital, Yes Bank pre-restructuring scrip etc.) at zero or fractional value. Selling forces the regret of crystallization. Holding preserves the fantasy that “it could come back”. This is regret aversion acting as a behavioral tax on portfolio hygiene.
(e) The “wait for the budget / wait for the result / wait for confirmation” loop. Indian investors disproportionately delay action around predictable calendar events — Union Budget, RBI policy, Q4 results, US Fed meetings. The objective expected-value impact of these events on a 10-year compounder is small. The regret-mitigation impact (being able to say “I waited to see what happened”) is large.
Counter-Measures: A Practical Anti-Regret Checklist
Regret aversion cannot be eliminated — it is hard-wired. But its damage to long-term compounding can be reduced by structural design. The following six-point checklist is drawn from behavioral-finance literature (especially Meir Statman’s Finance for Normal People, 2017, and Annie Duke’s Thinking in Bets, 2018) and translated to Indian retail conditions:
(1) Pre-commit through automation. SIPs, ECS mandates, NPS auto-debits, and quarterly rebalancing schedules remove the requirement for an in-the-moment decision. Anything pre-committed cannot be regretted in the moment of execution because the “decision” was made earlier, in a calmer state.
(2) Maintain a written investment policy statement (IPS). A one-page document specifying your asset-allocation bands, individual position-size limits, and the rules under which you sell. When the market moves, your IPS, not your gut, makes the call. Regret aversion is dramatically reduced when you can say “the IPS said sell” rather than “I sold”.
(3) Decision journaling. Before each material buy or sell, write down (a) the thesis, (b) the price, (c) the disconfirming evidence you would need to see, and (d) the time horizon. Twelve months later, re-read the entry. Over time the journal teaches you which of your impulses were process-correct and which were regret-driven.
(4) Pre-mortem the regret. Before each decision, explicitly ask: “If this turns out badly, what will I tell myself I should have done?” If the honest answer is “I should have stayed put”, you have evidence the decision is action-driven anxiety, not analysis. Conversely, if the answer is “I should have sized smaller”, that is a process input, not a regret signal.
(5) Separate the decision from the outcome. Annie Duke’s resulting framework — judge a decision by the quality of the process at the time it was made, not by what subsequently happened. Most regret is “resulting” in disguise.
(6) Use the 10-year filter. Ask: “Will I remember this individual decision ten years from now?” For 95% of buy/sell impulses, the honest answer is no — at which point regret aversion loses its grip.
How the Greats Addressed Regret Aversion
Benjamin Graham built regret-resistance into The Intelligent Investor through the concept of margin of safety. By buying with a price-to-value cushion, Graham ensured that even adverse outcomes did not produce regret-inducing capital impairment. The 1949 edition explicitly warns against “anguished post-mortems”, recommending instead a written checklist applied identically to every situation.
Warren Buffett has repeatedly said in his annual-meeting Q&A that he “doesn’t look at quotes” between purchase and reassessment. This is not laziness — it is regret-aversion management. By not exposing himself to intermediate price action, Buffett removes 95% of the counterfactual triggers that drive regret. He has also said (1996 Letter): “The fact that the market sometimes acts irrationally doesn’t mean I should — and the fact that I sometimes act irrationally doesn’t mean I should keep doing so.“
Charlie Munger was the most explicit. His “lattice of mental models” approach treats regret as an information signal, not a feeling: regret about a process failure (poor research, wrong sizing) is useful and should drive change; regret about an outcome from a sound process is noise and should be ignored. Munger frequently used the phrase “iron-prescribed indifference to outcome volatility“.
Seth Klarman in Margin of Safety (1991) writes that the inability to act on conviction during market panics is “not a courage problem; it is a regret-engineering problem“. Klarman’s solution at Baupost is institutional: pre-approved buy lists with pre-approved sizing, ready to execute on price triggers, removing the in-the-moment regret-aversion friction.
How Titan Biotech Ltd (BSE: 524717) Demonstrates Anti-Regret Process Discipline at the Corporate Level
One of the most useful diagnostic exercises a serious investor can run is to ask: “Does this company’s management exhibit the same anti-regret process discipline I am trying to build into my own portfolio?” A management team that runs the firm with clean balance-sheet hygiene, conservative capital allocation, and symmetric disclosure is, in process terms, doing what Graham/Buffett/Munger/Klarman are doing at the portfolio level. Titan Biotech Ltd, a small-cap fermentation-and-biotech business listed on BSE under code 524717, offers a clear illustrative example.
Consider eight specific FY25 markers from Titan Biotech’s audited consolidated accounts and what each one says about anti-regret process discipline at the corporate level:
| Marker | FY25 Number | Behavioural Interpretation (Anti-Regret Trait) |
|---|---|---|
| Total borrowings | ₹3 crore (down 81% from ₹16 Cr in FY21) | A near-zero-debt balance sheet pre-commits the firm out of distress scenarios. There is no leverage decision left to “regret” later. |
| CFO / Operating Profit | 103% (FY25); 85% (FY24); 97% (FY23) | When operating profit converts into hard cash >100%, the regret of “earnings that didn’t show up” is structurally avoided. Process > outcome. |
| Contingent liabilities | ₹7.78 Cr (FY25), down 39.7% YoY from ₹12.90 Cr | 5.08% of net worth — well below the 25% danger threshold. Reduces the size of the off-balance-sheet “regret tail”. |
| Depreciation as % of gross block | ~7.0% (peers ~4–5%) | Higher depreciation = more conservative wear-out assumptions. Reduces the regret of “we should have written it down sooner”. |
| CWIP discipline | ₹4 Cr (Sept 2025) vs FY23 peak of ₹13 Cr | CWIP that comes down rather than ballooning indicates capex projects are being commissioned, not deferred — an anti-regret-of-stranded-capital signal. |
| Quarterly revenue trajectory FY26 | ₹46.50 Cr → ₹54 Cr → ₹56 Cr (Q1 / Q2 / Q3 FY26) | Three consecutive QoQ increases indicate operational momentum, reducing regret of “did we time capacity wrong?” |
| Board independence | 4 of 11 directors independent (36.4%); 2 women (18.2%); independent chair; 14 board meetings in FY25 | Structural pre-commitment to challenge — exactly the anti-regret architecture Klarman recommends at the institutional level. |
| Export segment share | ~34.5% of FY25 revenue (Domestic ₹10,254.80 lakh + Overseas ₹5,390.28 lakh) | Geographic diversification removes single-currency / single-market regret. Anti-concentration discipline. |
The ten-year compounding record provides the outcome context: 10-year sales CAGR of 15%, 10-year profit CAGR of 29%, 5-year profit CAGR of 26%, ROCE of 16.9%, and ROE of approximately 15%. FY25 consolidated PAT was ₹22 crore, with FY26 revenue growing at roughly 19% TTM and a market cap of ₹1,779 crore at ₹430 (15 April 2026 reference). FY25 total director remuneration of ₹4.56 crore is the run-rate management cost against which all of the above process disciplines were delivered.
The purpose of citing these markers is purely instructional: to give a serious Indian investor a concrete visual of what anti-regret process discipline looks like in audited corporate accounts, so the same lens can be applied to every other holding in the portfolio.
Key Takeaways
To summarise the operational lessons of this article:
- Regret aversion is a 1982 academic concept (Bell; Loomes & Sugden) with hard real-world consequences for Indian retail wealth — most visibly in the ₹190+ lakh crore stuck in low-real-return FDs and the 4.2+ crore demat accounts holding defunct scrip.
- The cure is structural, not motivational. Automation (SIP, NPS, ECS), a written IPS, decision journaling, pre-mortems, the 10-year filter, and the resulting framework all work because they convert in-the-moment emotional decisions into pre-committed process.
- Inaction is itself a decision. The cost of “I’ll wait and see” compounds at the same rate as the cost of any other bad decision — but feels free because no commission was made.
- Titan Biotech FY25 illustrates anti-regret process at the corporate level: ₹3 crore borrowings (81% reduction from FY21), CFO/Operating-profit of 103%, contingent liabilities at 5.08% of net worth, ~7.0% depreciation rate, 36.4% independent board with 14 meetings, and ~34.5% export-segment share — eight independent markers of pre-committed process discipline. None of this is a valuation verdict; it is a corporate-process case study an investor can study and replicate-test against any holding in their own portfolio.
- Buffett’s rule applies: “Never look at the quotes between purchase and reassessment.” Less observation = less counterfactual = less regret = better long-term returns.
Disclaimer: This article is for educational and informational purposes only. It is not investment advice, and not a buy, sell, or hold recommendation on any stock mentioned, including Titan Biotech Limited. Equity markets carry risk; please do your own research or consult a qualified professional before making investment decisions.
